A Feature Selection Scheme for Accurate Identification of Alzheimer's Disease

Effective biomarkers play important roles for accurate diagnosis of Alzheimer’s Disease (AD), including its intermediate stage (i.e. mild cognitive impairment, MCI). In this paper, a new feature selection scheme was proposed to improve the identification AD and MCI from healthy controls (HC) by a support vector machine (SVM) based-classifier with recursive feature addition. Our method can find the significant features automatically, and the experiments in this work demonstrates that our scheme can achieve better classification performance based on a dataset with 103 subjects where three biomarkers, i.e., structural MR imaging (MRI), functional imaging PET, and cerebrospinal fluid(CSF), had been used. Our proposed method demonstrated its effectiveness in identifying AD from HC with an accuracy of 95.0 %, while only 89.3 % for the classifier without the step of feature selection. In addition, some features selected in this work had shown strong relation with AD by other previous studies, which can provide the support for the significance of our results.

[1]  M. Folstein,et al.  Clinical diagnosis of Alzheimer's disease , 1984, Neurology.

[2]  G. V. Van Hoesen,et al.  Neuropathologic changes of the temporal pole in Alzheimer's disease and Pick's disease. , 1994, Archives of neurology.

[3]  C. Jack,et al.  Prediction of AD with MRI-based hippocampal volume in mild cognitive impairment , 1999, Neurology.

[4]  Vladimir N. Vapnik,et al.  The Nature of Statistical Learning Theory , 2000, Statistics for Engineering and Information Science.

[5]  J. Hoffman,et al.  FDG PET imaging in patients with pathologically verified dementia. , 2000, Journal of nuclear medicine : official publication, Society of Nuclear Medicine.

[6]  D. Holtzman,et al.  Amyloid beta40/42 clearance across the blood-brain barrier following intra-ventricular injections in wild-type, apoE knock-out and human apoE3 or E4 expressing transgenic mice. , 2001, Journal of Alzheimer's disease : JAD.

[7]  J. Baron,et al.  Mapping gray matter loss with voxel-based morphometry in mild cognitive impairment , 2002, Neuroreport.

[8]  H. Ramaroson,et al.  Prévalence de la démence et de la maladie d'Alzheimer chez les personnes de 75 ans et plus : données réactualisées de la cohorte PAQUID , 2003 .

[9]  K. Ishii,et al.  Comparison of gray matter and metabolic reduction in mild Alzheimer’s disease using FDG-PET and voxel-based morphometric MR studies , 2005, European Journal of Nuclear Medicine and Molecular Imaging.

[10]  S. Leurgans,et al.  MRI-derived entorhinal volume is a good predictor of conversion from MCI to AD , 2004, Neurobiology of Aging.

[11]  P. Scheltens,et al.  Advances in the early detection of Alzheimer's disease , 2004, Nature Reviews Neuroscience.

[12]  Nick C. Fox,et al.  Differentiating AD from aging using semiautomated measurement of hippocampal atrophy rates , 2004, NeuroImage.

[13]  W. Klunk,et al.  Imaging brain amyloid in Alzheimer's disease with Pittsburgh Compound‐B , 2004, Annals of neurology.

[14]  C. Jack,et al.  Brain atrophy rates predict subsequent clinical conversion in normal elderly and amnestic MCI , 2005, Neurology.

[15]  Edward E. Smith,et al.  Cognitive Psychology: Mind and Brain , 2006 .

[16]  Dinggang Shen,et al.  Multivariate examination of brain abnormality using both structural and functional MRI , 2007, NeuroImage.

[17]  P. Scheltens,et al.  CSF biomarkers and medial temporal lobe atrophy predict dementia in mild cognitive impairment , 2007, Neurobiology of Aging.

[18]  Kathryn Ziegler-Graham,et al.  Forecasting the global burden of Alzheimer’s disease , 2007, Alzheimer's & Dementia.

[19]  Clifford R. Jack,et al.  Alzheimer's disease diagnosis in individual subjects using structural MR images: Validation studies , 2008, NeuroImage.

[20]  Xiaoying Wu,et al.  Structural and functional biomarkers of prodromal Alzheimer's disease: A high-dimensional pattern classification study , 2008, NeuroImage.

[21]  H. Benali,et al.  Support vector machine-based classification of Alzheimer’s disease from whole-brain anatomical MRI , 2009, Neuroradiology.

[22]  Christos Davatzikos,et al.  Baseline and longitudinal patterns of brain atrophy in MCI patients, and their use in prediction of short-term conversion to AD: Results from ADNI , 2009, NeuroImage.

[23]  J. Ashburner,et al.  Prognostic and Diagnostic Potential of the Structural Neuroanatomy of Depression , 2009, PloS one.

[24]  A. Dale,et al.  Alzheimer disease: quantitative structural neuroimaging for detection and prediction of clinical and structural changes in mild cognitive impairment. , 2009, Radiology.

[25]  A. Dale,et al.  Multi-modal imaging predicts memory performance in normal aging and cognitive decline , 2010, Neurobiology of Aging.

[26]  A. Dale,et al.  Combining MR Imaging, Positron-Emission Tomography, and CSF Biomarkers in the Diagnosis and Prognosis of Alzheimer Disease , 2010, American Journal of Neuroradiology.

[27]  C. Jack,et al.  Boosting power for clinical trials using classifiers based on multiple biomarkers , 2010, Neurobiology of Aging.

[28]  A. Dale,et al.  CSF Biomarkers in Prediction of Cerebral and Clinical Change in Mild Cognitive Impairment and Alzheimer's Disease , 2010, The Journal of Neuroscience.

[29]  Chih-Jen Lin,et al.  LIBSVM: A library for support vector machines , 2011, TIST.

[30]  J. Morris,et al.  The diagnosis of dementia due to Alzheimer’s disease: Recommendations from the National Institute on Aging-Alzheimer’s Association workgroups on diagnostic guidelines for Alzheimer's disease , 2011, Alzheimer's & Dementia.

[31]  Vikas Singh,et al.  Predictive markers for AD in a multi-modality framework: An analysis of MCI progression in the ADNI population , 2011, NeuroImage.

[32]  Daoqiang Zhang,et al.  Multimodal classification of Alzheimer's disease and mild cognitive impairment , 2011, NeuroImage.

[33]  Eric Westman,et al.  Combining MRI and CSF measures for classification of Alzheimer's disease and prediction of mild cognitive impairment conversion , 2012, NeuroImage.

[34]  A. Mechelli,et al.  Using Support Vector Machine to identify imaging biomarkers of neurological and psychiatric disease: A critical review , 2012, Neuroscience & Biobehavioral Reviews.

[35]  Jing Yang,et al.  Voxelwise meta-analysis of gray matter anomalies in Alzheimer's disease and mild cognitive impairment using anatomic likelihood estimation , 2012, Journal of the Neurological Sciences.

[36]  Peter A. Bandettini,et al.  Does feature selection improve classification accuracy? Impact of sample size and feature selection on classification using anatomical magnetic resonance images , 2012, NeuroImage.

[37]  Juan Manuel Górriz,et al.  Computer-aided diagnosis of Alzheimer's type dementia combining support vector machines and discriminant set of features , 2013, Inf. Sci..